comparemela.com

Latest Breaking News On - புற்றுநோய் ஆராய்ச்சி ப்ரோக்ர்யாம் - Page 1 : comparemela.com

DBT-NII receives Trademark for India s first indigenous tumour antigen SPAG9

New Delhi [India], June 4 (ANI): India's first indigenous tumour antigen, SPAG9 discovered by Dr Anil Suri, head of Cancer Research Program at Delhi based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), in 1998 has received the trademark ASPAGNII, the Ministry of Science and Technology informed on Friday.

NII receives Trademark for India s first indigenous tumour antigen SPAG9

DBT-NII Receives Trademark for India s First Indigenous Tumour Antigen SPAG9 – India Education | Latest Education News | Global Educational News

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.